Research and Development

The Food and Drug Administration has approved Gilead Sciences new treatment Zydelig (idelalisib) to treat three types of blood cancer.  …

Dr Dinesh Bhugra who has served as chair of the Mental Health Foundation for three years has been appointed as …

An investigation by The BMJ has raised fresh concerns about Boehringer’s top-selling blood thinner Pradaxa (dabigatran) and the regulatory decisions …

The Royal College of Nursing says that whilst a new wireless diagnostic patch is certainly innovative, they are concerned that …

Clinical diagnostics firm Agena Bioscience has confirmed that Peter Dansky has joined the company as its chief executive and will …

Allergan is to cut 1,500 jobs as part of a restructure which it believes will make pre-tax savings of around …

AZ’s MedImmune has entered into a clinical trial collaboration with US biotech firm Advaxis to help develop new cancer immunotherapies. …

 UK researchers are to gain access to compounds from seven pharma companies in a partnership with the Medical Research Council …

Healthcare research agency Cello Health Insight has made two director-level appointments on the back of a wave of new hires.

Just prior to landing in San Diego it was somewhat disconcerting to see fire spreading across the terrain and huge …

AstraZeneca’s new international HQ on the Cambridge Biomedical Campus (CBC), due to open in two years’ time, will feature an …

California-based speciality pharma firm Depomed has appointed Dr Srinivas Rao as its chief medical officer (CMO) and senior VP. Rao …

A Phase II clinical trial for Genentech’s investigational Alzheimer’s drug failed to meet its primary endpoints – but the company …

James Davis has been elected chairman of the national board of directors of The Leukemia & Lymphoma Society (LLS). Davis …

Bayer Healthcare has appointed Malini Moorthy to head up its litigation department in the US.  Moorthy joins the German firm from …